Sands Capital Ventures’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.67M | Hold |
724,873
| – | – | 0.33% | 19 |
|
|
2025
Q1 | $1.01M | Hold |
724,873
| – | – | 0.25% | 20 |
|
|
2024
Q4 | $1.25M | Hold |
724,873
| – | – | 0.27% | 19 |
|
|
2024
Q3 | $1.46M | Hold |
724,873
| – | – | 0.41% | 12 |
|
|
2024
Q2 | $1.62M | Hold |
724,873
| – | – | 0.54% | 11 |
|
|
2024
Q1 | $2.08M | Hold |
724,873
| – | – | 0.5% | 10 |
|
|
2023
Q4 | $1.28M | Hold |
724,873
| – | – | 0.36% | 13 |
|
|
2023
Q3 | $2.29M | Hold |
724,873
| – | – | 0.68% | 13 |
|
|
2023
Q2 | $478K | Hold |
724,873
| – | – | 0.14% | 14 |
|
|
2023
Q1 | $580K | Hold |
724,873
| – | – | 0.14% | 16 |
|
|
2022
Q4 | $1.64M | Hold |
724,873
| – | – | 0.45% | 15 |
|
|
2022
Q3 | $1.4M | Hold |
724,873
| – | – | 0.41% | 16 |
|
|
2022
Q2 | $2.7M | Hold |
724,873
| – | – | 0.74% | 16 |
|
|
2022
Q1 | $4.73M | Hold |
724,873
| – | – | 0.99% | 13 |
|
|
2021
Q4 | $8.45M | Hold |
724,873
| – | – | 1.25% | 11 |
|
|
2021
Q3 | $13.5M | Buy |
+724,873
| New | +$13.5M | 2.04% | 7 |
|